175 related articles for article (PubMed ID: 38753891)
1. The implementation and impact of non-invasive prenatal testing (NIPT) for Down's syndrome into antenatal screening programmes: A systematic review and meta-analysis.
Sebire E; Rodrigo CH; Bhattacharya S; Black M; Wood R; Vieira R
PLoS One; 2024; 19(5):e0298643. PubMed ID: 38753891
[TBL] [Abstract][Full Text] [Related]
2. Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units.
Chitty LS; Wright D; Hill M; Verhoef TI; Daley R; Lewis C; Mason S; McKay F; Jenkins L; Howarth A; Cameron L; McEwan A; Fisher J; Kroese M; Morris S
BMJ; 2016 Jul; 354():i3426. PubMed ID: 27378786
[TBL] [Abstract][Full Text] [Related]
3. Health economic evaluation of noninvasive prenatal testing and serum screening for down syndrome.
Xiao G; Zhao Y; Huang W; Hu L; Wang G; Luo H
PLoS One; 2022; 17(4):e0266718. PubMed ID: 35421148
[TBL] [Abstract][Full Text] [Related]
4. First trimester serum tests for Down's syndrome screening.
Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011975. PubMed ID: 26617074
[TBL] [Abstract][Full Text] [Related]
5. Implementation of non-invasive prenatal testing within a national UK antenatal screening programme: Impact on women's choices.
Bowden B; de Souza S; Puchades A; Williams K; Morgan S; Anderson S; Tucker D; Hillier S
Prenat Diagn; 2022 May; 42(5):549-556. PubMed ID: 35278232
[TBL] [Abstract][Full Text] [Related]
6. Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down's syndrome using cell free fetal DNA in the UK National Health Service.
Morris S; Karlsen S; Chung N; Hill M; Chitty LS
PLoS One; 2014; 9(4):e93559. PubMed ID: 24714162
[TBL] [Abstract][Full Text] [Related]
7. Second trimester serum tests for Down's Syndrome screening.
Alldred SK; Deeks JJ; Guo B; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2012 Jun; 2012(6):CD009925. PubMed ID: 22696388
[TBL] [Abstract][Full Text] [Related]
8. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
[TBL] [Abstract][Full Text] [Related]
9. National data on the early clinical use of non-invasive prenatal testing in public and private healthcare in Denmark 2013-2017.
Lund ICB; Petersen OB; Becher NH; Lildballe DL; Jørgensen FS; Ambye L; Skibsted L; Ernst A; Jensen AN; Fagerberg C; Brasch-Andersen C; Tabor A; Zingenberg HJ; Nørgaard P; Almind GJ; Vestergaard EM; Vogel I
Acta Obstet Gynecol Scand; 2021 May; 100(5):884-892. PubMed ID: 33230826
[TBL] [Abstract][Full Text] [Related]
10. Second tier non-invasive prenatal testing in a regional prenatal diagnosis service unit: a retrospective analysis and literature review.
Ng VKS; Chan AL; Lau WL; Leung WC
Hong Kong Med J; 2020 Feb; 26(1):10-18. PubMed ID: 32051331
[TBL] [Abstract][Full Text] [Related]
11. Has noninvasive prenatal testing impacted termination of pregnancy and live birth rates of infants with Down syndrome?
Hill M; Barrett A; Choolani M; Lewis C; Fisher J; Chitty LS
Prenat Diagn; 2017 Dec; 37(13):1281-1290. PubMed ID: 29111614
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol.
Hill M; Wright D; Daley R; Lewis C; McKay F; Mason S; Lench N; Howarth A; Boustred C; Lo K; Plagnol V; Spencer K; Fisher J; Kroese M; Morris S; Chitty LS
BMC Pregnancy Childbirth; 2014 Jul; 14():229. PubMed ID: 25027965
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2019; 19(4):1-166. PubMed ID: 30847010
[TBL] [Abstract][Full Text] [Related]
14. First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.
Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012600. PubMed ID: 28295158
[TBL] [Abstract][Full Text] [Related]
15. Urine tests for Down's syndrome screening.
Alldred SK; Guo B; Takwoingi Y; Pennant M; Wisniewski S; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011984. PubMed ID: 26662198
[TBL] [Abstract][Full Text] [Related]
16. First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.
Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012599. PubMed ID: 28295159
[TBL] [Abstract][Full Text] [Related]
17. Cytogenomic results following high-chance non-invasive prenatal testing: a UK national audit.
Togneri FS; Allen SK; Mann K; Holgado E; Morgan S
Genet Res (Camb); 2020 Sep; 102():e7. PubMed ID: 32867862
[TBL] [Abstract][Full Text] [Related]
18. Will the introduction of non-invasive prenatal testing for Down's syndrome undermine informed choice?
Silcock C; Liao LM; Hill M; Chitty LS
Health Expect; 2015 Oct; 18(5):1658-71. PubMed ID: 26039796
[TBL] [Abstract][Full Text] [Related]
19. The potential impact of NIPT as a second-tier screen on the outcomes of high-risk pregnancies with rare chromosomal abnormalities.
Maxwell S; Dickinson JE; Murch A; O'Leary P
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):420-6. PubMed ID: 26286670
[TBL] [Abstract][Full Text] [Related]
20. Obstetric professionals' perceptions of non-invasive prenatal testing for Down syndrome: clinical usefulness compared with existing tests and ethical implications.
Ngan OMY; Yi H; Wong SYS; Sahota D; Ahmed S
BMC Pregnancy Childbirth; 2017 Sep; 17(1):285. PubMed ID: 28870159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
